A Cross-Level Information Transmission Network for Predicting Phenotype
  from New Genotype: Application to Cancer Precision Medicine
  An unsolved fundamental problem in biology and ecology is to predict
observable traits (phenotypes) from a new genetic constitution (genotype) of an
organism under environmental perturbations (e.g., drug treatment). The
emergence of multiple omics data provides new opportunities but imposes great
challenges in the predictive modeling of genotype-phenotype associations.
Firstly, the high-dimensionality of genomics data and the lack of labeled data
often make the existing supervised learning techniques less successful.
Secondly, it is a challenging task to integrate heterogeneous omics data from
different resources. Finally, the information transmission from DNA to
phenotype involves multiple intermediate levels of RNA, protein, metabolite,
etc. The higher-level features (e.g., gene expression) usually have stronger
discriminative power than the lower level features (e.g., somatic mutation). To
address above issues, we proposed a novel Cross-LEvel Information Transmission
network (CLEIT) framework. CLEIT aims to explicitly model the asymmetrical
multi-level organization of the biological system. Inspired by domain
adaptation, CLEIT first learns the latent representation of high-level domain
then uses it as ground-truth embedding to improve the representation learning
of the low-level domain in the form of contrastive loss. In addition, we adopt
a pre-training-fine-tuning approach to leveraging the unlabeled heterogeneous
omics data to improve the generalizability of CLEIT. We demonstrate the
effectiveness and performance boost of CLEIT in predicting anti-cancer drug
sensitivity from somatic mutations via the assistance of gene expressions when
compared with state-of-the-art methods.
